Briefly Bio is a biotech platform that provides a solution to make lab work reproducible.
Briefly Bio has raised $1.2M in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2024.
Briefly Bio's investors include Compound, NP-Hard Ventures, Tiny VC.
Briefly Bio is headquartered in London, United Kingdom.
Briefly Bio is a biotech platform that provides a solution to make lab work reproducible.
Briefly Bio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Briefly Bio — Funding & Investors." VCBacked, July 17, 2024, https://www.vcbacked.co/company/briefly-bio. Accessed August 1, 2026.
VCBacked. (2024). Briefly Bio — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/briefly-bio
{{cite web |title=Briefly Bio — Funding & Investors |url=https://www.vcbacked.co/company/briefly-bio |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated